On morning of April 22, 2015, seminar of project of pRetrospective management style of high-risky medical deviceq entrusted by the China Food and Drug Administration (CFDA) was held successfully in Meeting Room Sidong 611. The seminar was hosted by Li Jiangning, Department Director of Beijing Food and Drug Administration. 29 people attended the seminar including Secretary Tong Min of Department of Medical Device Supervision of CFDA, Director Chen Lei of Division of General Affairs of Department of Medical Device Supervision of CFDA, Director Huang Qin of Division of Distribution Supervision of General Affairs of Department of Medical Device Supervision of CFDA, Director Li Jun of Center of Standards Management of Medical Device of CFDA, Director Zhang Yongjian of Research Center for Development and Regulation of Food and Drug Industry of Chinese Academy of Social Sciences, Secretary-General Wei Bin of Beijing Chamber of Commerce for Medical Devices, delegates from enterprises such as China National Medical Device Co., Ltd., and Vice President and Prof. Shi Xianliang of School of Economics and Management, President and Prof. Zhang Juliang of Sub-School of Management Enginerring, Dean and Prof. Li Yisong of Department of Logistical Management, Prof. Lan Hongjie and Associated Prof. Hua Guowei of Department of Logistical Management.
 

Prof. Shi Xianliang first gave a warm welcome to Secretary Tong Min and his colleagueso visit, and made an introduction to the basic circumstances, history and development status of School of Economics and Management. Then Secretary Tong Min said that coding and retrospective management of high-risky medical device had been received high attention of the state, emphasizing our country should create coding and retrospective management system based on learning from foreign countries and considering our own national conditions. He also proposed three possible styles of coding and retrospective management. Director Li Jun made a brief introduction to current conditions of international medical device coding and retrospective management.
 

Then, experts and enterprise delegates put forward the requirements and expectations to CFDA as for the creation of coding and retrospective management system of high-risky medical device and gave their suggestion from angles of producing enterprises, logistical enterprises, application units, technical feasibility, etc. They also expressed recognition and urgent needs for creation of coding and retrospective management system of high-risky medical device.
 

Finally, Secretary Tong Min summarized preliminary consensus of the seminar from 6 aspects of coding characteristics, responsibility division, retrospective style, docking of new and old systems, information recording forms, and degree of information disclosure. He said that the seminar had determined general direction for research of retrospective management style of high-risky medical device and laid foundation for future work.
 

The successful development of this project will certainly provide a suit of practical coding system and retrospective management style for scientific supervision of our countryos medical devices in the loops of production, logistics and application. It will also provide guarantee and foundation for regulating medical device market operation, avoiding and controlling risks, dividing risky responsibilities, etc.